Entvin

Entvin — Standardised, versioned global drug-label and product-authorisation corpus exposed as a REST API: approved product information normalised across 20+ regulatory authorities (US FDA, EMA, Health Canada, TGA, UK MHRA, Swissmedic, PMDA, SAHPRA, BfArM), sectioned into structured fields (product information, contraindications, adverse reactions, warnings and precautions), with retained version history, side-by-side cross-geography label comparison, approval-status and marketing-authorisation-holder attributes, and a change-event stream powering new-molecule-launch and label-update notifica…

Entvin offers (Reference, Alternative, Fundamental) — est. high hundreds of thousands of product-label documents — 20+ authorities each publishing their own approved-product-information set, every document retained across multiple versions, so version lineage multiplies a six-figure base document count into a larger versioned record set.

Explicitly targets AI/ML: feeding structured drug metadata into LLM pipelines and prediction models, training models on regulatory-approved content, and generating compliant medical content. Also competitive regulatory intelligence and market-entry strategy, automated label authoring and labelling-workflow compliance, pharma SaaS enrichment, and longitudinal label-change modelling for pharmacovigilance and safety-textual-change detection.

The data is with 4 years of history.

Coverage spans US, Japan, UK, APAC, Other, China/HK; Financial Exchanges & Data, Pharmaceuticals; reference, alternative, fundamental; equities.